文献速递眼底病与葡萄膜炎

京尼平交联供体巩膜行后巩膜收缩/加固术控制进行性近视

Genipin-Crosslinked Donor Sclera for Posterior Scleral Contraction/Reinforcement to Fight Progressive Myopia.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

随访2至3年,手术眼眼轴增加0.32 mm,对照眼增加0.82 mm(P < 0.001,配对t检验),手术眼与对照眼在视力、角膜屈光力或视网膜厚度方面无显著变化。

要点

  • 手术眼眼轴随访期间增加0.32 mm,对照眼增加0.82 mm(P < 0.001,配对t检验)。
  • PSCR在有或无巩膜葡萄肿的眼中均延缓眼轴延长。
  • 手术眼与对照眼在视力、角膜屈光力或视网膜厚度方面无显著变化,无患者视力较基线下降。

核心结论

  • 京尼平交联巩膜PSCR在2至3年随访期内对年轻患者 restrain 眼球延长安全有效。

主要发现

  • 手术眼眼轴在术后即刻缩短,随后在随访期内增加0.32 mm;对照眼眼轴同期增加0.82 mm(P < 0.001,配对t检验)。
  • PSCR在有或无巩膜葡萄肿的眼中均延缓眼轴延长。
  • 手术眼与对照眼在视力、角膜屈光力或视网膜厚度方面无显著变化。
  • 无患者视力较基线下降。
  • 手术耐受良好,仅出现暂时性角膜屈光轴移位,至术后6个月随访时恢复。

临床怎么用

  • 原文结论为PSCR with genipin-crosslinked sclera is safe and effective to restrain eye globe elongation in young patients within a 2- to 3-year follow-up period。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Myopia has become a global public health problem, particularly in East Asia where myopic retinopathy has become one of the leading causes of blindness and visual impairment in the elderly population. The purpose of this study was to evaluate the efficacy of posterior scleral contraction/reinforcement (PSCR) surgery on controlling the progressive elongation of axial length of highly myopic eyes in young patients. METHODS: This is a prospective self-controlled interventional case series. Forty young patients (<18-years old) with progressive high myopia received PSCR with a genipin-crosslinked donor scleral strip for one eye and the fellow eye served as concurrent control without surgery. The main outcome measurement was the change of axial length over 2 to 3 years of follow-up. RESULTS: Immediately after the surgery, axial length was shortened and subsequently increased by 0.32 mm over the follow-up period. In contrast, axial length of the fellow eyes increased by 0.82 mm over the same period (P < 0.001, paired t-test). PSCR delayed axial elongation in eyes with or without staphyloma. No significant change of visual acuity, cornea refractive power, or retina thickness was noted between the surgery and fellow eyes. None of the patients lost visual acuity compared with the baseline. The procedure was well tolerated with only temporary corneal refractive axis shifts that recovered by the 6-month postsurgical visit. CONCLUSIONS: PSCR with genipin-crosslinked sclera is safe and effective to restrain eye globe elongation in young patients within a 2- to 3-year follow-up period.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Xue A, Zheng L, Tan G, et al. Genipin-Crosslinked Donor Sclera for Posterior Scleral Contraction/Reinforcement to Fight Progressive Myopia. Invest Ophthalmol Vis Sci. 2018. PMID: 30025077. doi:10.1167/iovs.17-23707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。